Lv6
2672 积分 2022-04-11 加入
Nanobody-based targeted cancer therapy and immunotherapy: fear not the future
7天前
已完结
Malignant ascites as an immune organ and implications for cancer immunotherapy
7天前
已完结
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial
11天前
已完结
Predominant Autoantibody Production by Early Human B Cell Precursors
11天前
已完结
Progress in the development of cytokine armoured CAR T cells
15天前
已完结
Reprogramming CAR with cytokine signaling increases the efficacy of CAR-T cell therapy in solid tumour treatment and confers sustained immune memory
15天前
已完结
Interleukin-23 engineering improves CAR T cell function in solid tumors
16天前
已完结
Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy
17天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
17天前
已完结
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target
18天前
已完结
DB-1317 - AdisInsight
5个月前
已驳回
皖公网安备34019202002308
